Scorpius BioManufacturing, a Texas-based biologics contract development and manufacturing organisation (CDMO), announced Thursday that it has named Joe Payne as its new vice president, Quality and Regulatory Affairs.
In the new role, Payne will be responsible for ensuring quality and compliance remain at the forefront of the company's biomanufacturing capabilities.
Payne has over 20 years of experience in the biopharma and pharmaceutical industry, including leadership roles at Contract Development and Manufacturing Organizations (CDMOs), Alcami Corporation and Tergus Pharma, as well as large pharma, Teva Pharmaceuticals.
Viatris adds new board director
Bloom Science names new board chair
Prescient Healthcare names new directors
Alcami names new general manager, Biostorage and Pharma Services
Cell Easy Appoints CDMO Expert Dr. Sebastien Ribault as Independent Board Director
Nexus Pharmaceuticals Appoints Two New Board Members
Scorpius BioManufacturing names new vice president, Quality and Regulatory Affairs
NeuroTrauma Sciences names new CMO and EVP of Regulatory Affairs and Quality Assurance